How is Mounjaro different from semaglutide-only medicines?

Have a query?
How is Mounjaro different from semaglutide-only medicines?
Asked by Male, 24 · 7 days ago
Other Related topics like...
Mounjaro (tirzepatide) differs from semaglutide-only medications mainly in its dual receptor activity and effects.
Mounjaro activates both GIP (glucose-dependent insulin polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, while semaglutide targets only the GLP-1 receptor. This dual action enhances insulin release and blood sugar control more effectively.
Because of its dual receptor targeting, Mounjaro often provides greater improvements in blood sugar regulation and weight loss compared to semaglutide alone.
Mounjaro is given as a subcutaneous injection, typically starting from 2.5 mg and adjustable up to higher doses, whereas semaglutide is available both as injection and oral tablets (like Rybelsus 3 mg), with differing administration schedules. Mounjaro dosing is adjusted by a healthcare provider.
Both medications can cause nausea, vomiting, abdominal discomfort, and headache. Mounjaro may have slightly higher rates of gastrointestinal side effects due to its dual receptor effects. Patients with history of pancreatitis, kidney or liver disease should share this with their doctor before starting either medication.
Consult an endocrinologist or diabetes specialist for personalized advice and to determine which medicine suits your specific health needs best.
Answered 7 days ago